Account
06.11.2024 14:00 PM GMT
WEBINAR
Event Host
Dr Paul Craddy and Dr Graham Foxon
Event Description

Join us for the latest instalment in our EU HTA webinar series where we’ll explore the ground-breaking insights and practical learnings from one of the first Joint Scientific Consultations (JSCs). Hosted by Remap Consulting’s Managing Directors, Graham Foxon and Paul Craddy, this exclusive event delves into the JSC process and shares strategic takeaways from a real-world case study.

We’ll cover:

  • Understanding the JSC process: why JSCs are becoming crucial for product success
  • The strategic value of early engagement with Health Technology Assessments (HTAs)
  • Real-world challenges and solutions from one of the first JSC submissions
  • Practical tips on how to implement JSCs and optimise your HTA and regulatory strategy
  • The evolving role of JSCs and what the future holds

Why attend?
You will gain unparalleled insights into the JSC process, clarity on the value of early-stage scientific advice and actionable steps to navigate the evolving landscape of JSCs towards your product’s success. This webinar is valuable for market access professionals, regulatory affairs specialists, and anyone involved in strategic planning and regulatory submissions. Save your seat today by clicking the link below!

Plus, in the meantime, check out our EU HTA resource library here.

Register Now

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.